Clearside Biomedical Inc buy Needham & Company LLC
Start price
11.04.24
/
50%
€1.23
Target price
11.04.25
€3.72
Performance (%)
-27.64%
Price
23.08.24
€0.89
Summary
This prediction is currently active. The prediction for Clearside Biomedical Inc disappoints with a performance of -27.64%. This prediction currently runs until 11.04.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Clearside Biomedical Inc | -5.820% | -5.820% |
iShares Core DAX® | 1.665% | 1.692% |
iShares Nasdaq 100 | -0.475% | 1.483% |
iShares Nikkei 225® | 2.620% | 4.475% |
iShares S&P 500 | -0.091% | 1.099% |
Comments by Needham___Company_LL for this prediction
In the thread Clearside Biomedical Inc diskutieren
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $4.00 price target on the stock.
Ratings data for CLSD provided by MarketBeat
Stopped prediction by Needham___Company_LL for Clearside Biomedical Inc
Clearside Biomedical Inc
Start price
Target price
Perf. (%)
€0.92
13.08.24
13.08.24
€3.66
13.08.25
13.08.25
-5.98%
23.08.24
23.08.24
Clearside Biomedical Inc
Start price
Target price
Perf. (%)
€1.03
25.07.24
25.07.24
€3.69
25.07.25
25.07.25
-16.02%
23.08.24
23.08.24
Clearside Biomedical Inc
Start price
Target price
Perf. (%)
€1.09
13.05.24
13.05.24
€3.70
13.05.25
13.05.25
-20.64%
23.08.24
23.08.24
Clearside Biomedical Inc
Start price
Target price
Perf. (%)
€0.88
15.08.23
15.08.23
€3.66
15.08.24
15.08.24
7.39%
16.08.24
16.08.24
Clearside Biomedical Inc
Start price
Target price
Perf. (%)
€0.98
20.04.23
20.04.23
€3.65
20.04.24
20.04.24
22.05%
21.04.24
21.04.24